| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 20, 2024 | HIMS Hims & Hers Health, Inc. | Chi Michael | Chief Commercial Officer | Sell | 7,500 | $24.50 | $183,750.00 | -3.9% | -27.2% | +186.8% | |
| Jun 20, 2024 | LLY Eli Lilly & Co | Lilly Endowment Inc | - | Sell | 9,671 | $902.67 | $8,729,732.99 | - | +2.1% | -13.9% | |
| Jun 20, 2024 | ANIP Ani Pharmaceuticals Inc | Shanmugam Muthusamy59 | Head Of R&D, Coo-novitium Ops | Sell | 30,000 | $60.59 | $1,817,662.60 | -1.4% | +2.8% | +10.4% | |
| Jun 18, 2024 | UTHR United Therapeutics Corp | Causey Christopher59 | Director | Sell | 3,000 | $304.18 | $912,538.50 | -41.8% | +12.7% | -4.7% | |
| Jun 18, 2024 | ESPR Esperion Therapeutics, Inc. | Foody Joanne M.73 | Chief Medical Officer | Sell | 3,285 | $2.87 | $9,418.10 | -1.2% | -35.3% | -59.6% | |
| Jun 18, 2024 | TEVA Teva Pharmaceutical Industries Ltd | Mignone Roberto | Director | Sell | 519,000 | $17.03 | $8,838,570.00 | -34.6% | +6.2% | +0.3% | |
| Jun 18, 2024 | ESPR Esperion Therapeutics, Inc. | Warren Eric60 | Chief Commercial Officer | Sell | 2,540 | $2.86 | $7,254.24 | -1.5% | -35.3% | -59.6% | |
| Jun 18, 2024 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 7,200 | $298.57 | $2,149,728.18 | -16.4% | +12.7% | -4.7% | |
| Jun 18, 2024 | VRNO Verano Holdings Corp. | Kalesnik Laura Marie | See Remarks | Sell | 34,819 | $3.57 | $124,243.39 | -11.0% | - | - | |
| Jun 18, 2024 | VRNO Verano Holdings Corp. | Spreckman David | Chief Marketing Officer | Sell | 28,334 | $3.56 | $100,749.44 | -11.2% | - | - | |
| Jun 18, 2024 | HIMS Hims & Hers Health, Inc. | Chi Michael | Chief Commercial Officer | Sell | 25,549 | $23.59 | $602,700.91 | -12.1% | -34.3% | +146.3% | |
| Jun 18, 2024 | VRNO Verano Holdings Corp. | Summerer Brett Andrew | Chief Financial Officer | Sell | 83,820 | $3.48 | $291,609.53 | -28.2% | - | - | |
| Jun 18, 2024 | VRNO Verano Holdings Corp. | Weiss Darren Henry | President | Sell | 79,897 | $3.51 | $280,725.39 | -6.5% | - | - | |
| Jun 18, 2024 | VRNO Verano Holdings Corp. | Tipton John Allen | See Remarks | Sell | 52,212 | $3.48 | $181,564.22 | -0.8% | - | - | |
| Jun 18, 2024 | HIMS Hims & Hers Health, Inc. | Becklund Irene | Pao | Sell | 13,713 | $23.61 | $323,730.39 | -41.8% | -34.3% | +146.3% | |
| Jun 18, 2024 | VRNO Verano Holdings Corp. | McDermott Edward Aloysious III | Chief Operating Officer | Sell | 39,070 | $3.55 | $138,821.41 | -16.6% | - | - | |
| Jun 17, 2024 | LLY Eli Lilly & Co | Lilly Endowment Inc | - | Sell | 194,978 | $885.91 | $172,733,708.05 | - | +4.4% | -10.6% | |
| Jun 17, 2024 | BSPK Bespoke Extracts, Inc. | Feinsod Michael | CEO | Buy | 4,000 | $0.13 | $520.00 | +0.2% | - | - | |
| Jun 17, 2024 | BCRX Biocryst Pharmaceuticals Inc | Sanders MacHelle45 | Director | Sell | 4,689 | $6.00 | $28,134.00 | -14.5% | +26.8% | +59.8% | |
| Jun 17, 2024 | UTHR United Therapeutics Corp | Patusky Christopher50 | Director | Sell | 2,000 | $295.50 | $591,000.00 | -100% | +16.1% | -3.4% | |
| Jun 17, 2024 | UTHR United Therapeutics Corp | Olian Judy D.60 | Director | Sell | 1,700 | $295.43 | $502,225.39 | -23.3% | +16.1% | -3.4% | |
| Jun 17, 2024 | BTAI Bioxcel Therapeutics, Inc. | Wiley Matthew T.82 | Chief Commercial Officer | Sell | 244 | $1.26 | $308.10 | -6.5% | -51.9% | -92.3% | |
| Jun 17, 2024 | BTAI Bioxcel Therapeutics, Inc. | Mehta Vimal92 | CEO And President | Sell | 2,134 | $1.28 | $2,738.99 | -4.3% | -51.9% | -92.3% | |
| Jun 17, 2024 | BTAI Bioxcel Therapeutics, Inc. | Yocca Frank88 | Chief Scientific Officer | Sell | 372 | $1.28 | $476.16 | -2.7% | -51.9% | -92.3% | |
| Jun 17, 2024 | BTAI Bioxcel Therapeutics, Inc. | Rodriguez Javier87 | See Remarks | Sell | 361 | $1.26 | $456.02 | -4.1% | -51.9% | -92.3% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.